Opportunities in somatostatin research: biological, chemical and therapeutic aspects.
Weckbecker
Gisbert
G
Transplantation and Immunology, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland. gisbert.weckbecker@pharma.novartis.com
Lewis
Ian
I
Albert
Rainer
R
Schmid
Herbert A
HA
Hoyer
Daniel
D
Bruns
Christian
C
D000172:Acromegaly / Q000188:drug therapy / Q000378:metabolism; D000818:Animals; D035843:Biomedical Research / Q000379:methods*; D004701:Endocrine Gland Neoplasms / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D015394:Molecular Structure; D011986:Receptors, Somatotropin / Q000737:chemistry / Q000378:metabolism* / Q000502:physiology; D015398:Signal Transduction; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use*
D011986:Receptors, Somatotropin; D013004:Somatostatin